BDF Gestion’s Royalty Pharma RPRX Stock Holding History

BDF Gestion’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.1M	Sell	18,865 -2,393	-11%	-$141K	0.15%	137
2026 Q2	$1.88M	Sell	21,258 -2,391	-10%	-$124K	0.25%	104
2026 Q1	$1.13M	Hold	23,649	–	–	0.15%	135
2025 Q4	$914K	Sell	23,649 -1,576	-6%	-$60.1K	0.11%	141
2025 Q3	$890K	Sell	25,225 -5,246	-17%	-$190K	0.11%	139
2025 Q2	$1.1M	Sell	30,471 -3,321	-10%	-$110K	0.12%	132
2025 Q1	$1.05M	Hold	33,792	–	–	0.11%	136
2024 Q4	$862K	Sell	33,792 -4,389	-11%	-$116K	0.09%	134
2024 Q3	$10M	Hold	38,181	–	–	1.08%	16
2024 Q2	$1.01M	Buy	+38,181	New	+$1.06M	0.1%	148

Other funds holding RPRX

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Triasima Portfolio Management Montreal, Quebec, Canada $758M AUM 48.16% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

BDF Gestion's RPRX Position: Q3 2026 in Review

BDF Gestion reduced its Royalty Pharma (RPRX) stake by 11% in Q3 2026, selling an estimated $141K and leaving 18,865 shares worth $1.1M. The position accounts for 0.15% of the portfolio, ranked #137.

BDF Gestion first reported a position in RPRX in Q2 2024 and has held it in 10 quarters since. The position peaked at $10M in Q3 2024. 72 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

BDF Gestion held 18,865 shares of Royalty Pharma worth $1.1M as of Q3 2026.
BDF Gestion sold 2,393 Royalty Pharma shares in Q3 2026, an estimated $141K.
Royalty Pharma made up 0.15% of BDF Gestion's portfolio in Q3 2026, its #137 holding.
BDF Gestion first reported a position in Royalty Pharma in Q2 2024 and has held it in 10 quarters since.
BDF Gestion's Royalty Pharma position peaked at $10M in Q3 2024.
72 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on BDF Gestion's 13F filing for Q3 2026, filed 19 Oct 2026.